K

Kijimea

Overview

Work here?Claim your company

About Kijimea

Simplify's Rating
Why Kijimea is rated
B-
Rated B on Competitive Edge
Rated B on Growth Potential
Rated C on Differentiation

Industries

BiotechnologyHealthcare

Company Size

N/A

Company Stage

N/A

Total Funding

N/A

Headquarters

Gräfelfing, Germany

Founded

2020

Simplify Jobs

Simplify's take

What believers are saying

  • June 26, 2026 pack-size expansion in Germany, Austria, and Italy widens purchase options.
  • Kijimea Inc. ships U.S. orders in 2-5 business days from 120 Wall Street.
  • Open roles numbered 37 on November 9, 2026, signaling active hiring.

What critics are saying

  • A November 5, 2026 NRZ article says experts doubt Kijimea's diarrhea claims.
  • The U.S. launch relies on sponsored PR, not independent clinical validation.
  • If regulatory scrutiny grows, Kijimea's probiotic efficacy story collapses in pharmacies and e-commerce.

What makes Kijimea unique

  • Kijimea pairs patented B. bifidum HI-MIMBb75 with pharmacy-style trust and German branding.
  • Its 2023 Shopify Germany store and 2026 U.S. launch unify offline and online sales.
  • K53, PRO, and Women show a focused portfolio, not a commodity supplement catalog.

Help us improve and share your feedback! Did you find this helpful?

Recently Posted Jobs

Sign up to get curated job recommendations

Kijimea is Hiring for 38 Jobs on Simplify!

Find jobs on Simplify and start your career today

Don't see your dream role? Check out thousands of other roles on Simplify.Browse all jobs